TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10924665

Group type: EXPERIMENTAL
Intervention: Bilateral ECT with low-dose stimulus intensity (just above seizure threshold)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Bilateral ECT with two-fold stimulus intensity
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Bilateral ECT with four-fold stimulus intensity
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Bilateral ECT (all dosage groups)
Number of subjects: 62
Study: 1954636

Group type: EXPERIMENTAL
Intervention: Idarubicin (IDA) 12 mg/m2 daily for 3 days + Cytosine arabinoside 200 mg/m2 daily for 5 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Daunorubicin (DNR) 50 mg/m2 daily for 3 days + Cytosine arabinoside 200 mg/m2 daily for 5 days
Number of subjects: 120
Study: 6908875

Group type: EXPERIMENTAL
Intervention: Long-term gestagen therapy (100 mg medrogestone or medroxyprogesterone acetate daily for 2-5 years)
Number of subjects: 124
Study: 31790979

Group type: EXPERIMENTAL
Intervention: Acute abstinence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30479087

Group type: EXPERIMENTAL
Intervention: Paclitaxel-based hyperthermic intraperitoneal chemotherapy (HIPEC) with 175 mg/m² for 90 minutes after interval debulking surgery (IDS)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Interval debulking surgery (IDS) followed by HIPEC
Number of subjects: 65
Study: 29262749

Group type: EXPERIMENTAL
Intervention: Externally focused exercise
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Internally focused exercise
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (16 participants)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both exercise groups (External and Internal)
Number of subjects: 47
Study: 26162889

Group type: EXPERIMENTAL
Intervention: Bilevel NIPPV
Number of subjects: 456

Group type: COMPARATOR
Intervention: CMV NIPPV
Number of subjects: 456
Study: 24882554

Group type: EXPERIMENTAL
Intervention: Sunitinib 50mg daily (4 weeks on, 2 weeks off)
Number of subjects: 34
Study: 23073596

Group type: EXPERIMENTAL
Intervention: Bovine porous bone mineral (BPBM) containing bone morphogenetic proteins (BMP)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Bovine porous bone mineral (BPBM) alone
Number of subjects: 9
Study: 19915083

Group type: EXPERIMENTAL
Intervention: 100 ppm HFC-245fa
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 300 ppm HFC-245fa
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (0 ppm HFC-245fa)
Number of subjects: 10
Study: 16500662

Group type: EXPERIMENTAL
Intervention: Simvastatin 20mg
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Combined therapy (Simvastatin 20mg and Losartan 100mg)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Losartan 100mg
Number of subjects: 47
Study: 15599947

Group type: EXPERIMENTAL
Intervention: Family intervention (usual care plus family intervention); 5 sessions addressing family involvement, optimistic attitude, coping effectiveness, uncertainty reduction, and symptom management
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Family intervention (usual care plus family intervention)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 134
Study: 12081828

Group type: EXPERIMENTAL
Intervention: Dietary chromium supplementation
Number of subjects: 618
Study: 9925869

Group type: EXPERIMENTAL
Intervention: Mogen clamp with DPNB
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Mogen clamp without DPNB
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Gomco clamp with DPNB
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Gomco clamp without DPNB
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: DPNB
Number of subjects: 48

Group type: COMPARATOR
Intervention: No DPNB
Number of subjects: 48
Study: 7496451

Group type: EXPERIMENTAL
Intervention: Turning by an oscillating bed
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard 2-hour turning
Number of subjects: 103
Study: 2215826

Group type: EXPERIMENTAL
Intervention: Calcitonin (415 pmol i.v. bolus followed by a 90‐min infusion, total dose 62.25 pmol.kg‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Calcitonin
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 6298156

Group type: EXPERIMENTAL
Intervention: Mixed beam radiation therapy (neutron treatment)
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Neutron treatment
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Preoperative mixed beam irradiation
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Mixed beam irradiation alone
Number of subjects: 2500
Study: 31421426

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) therapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no LMWH therapy)
Number of subjects: 36
Study: 30160050

Group type: EXPERIMENTAL
Intervention: Brody score cut-off of 3.6 in PEIT for ≥0.3 annual pulmonary exacerbations
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Brody score cut-off of 2.1 in WI RCT for ≥0.3 annual pulmonary exacerbations
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Brody CT score
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: FEV1 % predicted
Number of subjects: 141
Study: 26986096

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR-based triple therapy (60 mg once daily, clarithromycin 500 mg twice daily, amoxicillin 1 g twice daily)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Rabeprazole-based triple therapy (20 mg twice daily, clarithromycin 500 mg twice daily, amoxicillin 1 g twice daily)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR-based triple therapy
Number of subjects: 177

Group type: COMPARATOR
Intervention: Rabeprazole-based triple therapy
Number of subjects: 177
Study: 25201463

Group type: EXPERIMENTAL
Intervention: Mg + H2 group
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Mg group
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 450
Study: 22534403

Group type: EXPERIMENTAL
Intervention: High progesterone group (mid-luteal phase)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Low progesterone group (non-luteal phases)
Number of subjects: 56
Study: 20447229

Group type: EXPERIMENTAL
Intervention: Drug dependence treatment trials
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Trials comparing widely different treatments
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Experiments with large samples
Number of subjects: 98
Study: 18490084

Group type: EXPERIMENTAL
Intervention: Infants with apnea who participated in the vaccine trial
Number of subjects: 175

Group type: COMPARATOR
Intervention: Very low birth weight (VLBW) infants control group
Number of subjects: 175

Group type: COMPARATOR
Intervention: Infants from the vaccine trial control group
Number of subjects: 175
Study: 15689431

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 30059

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 30059
Study: 12585782

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Systematic walking program for 12 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control Group (CG) - No walking program
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Systematic walking program
Number of subjects: 52
Study: 10507206

Group type: EXPERIMENTAL
Intervention: Gamma irradiation (25.2 kGy)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (water at 20 degrees C for 12 days)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Freezing (-18 degrees C for 12 days)
Number of subjects: 21
Study: 7571769

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (2 x 40 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nisoldipine (2 x 10 mg)
Number of subjects: 24
Study: 1943183

Group type: EXPERIMENTAL
Intervention: University of Wisconsin solution (UW)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Stanford solution
Number of subjects: 29
Study: 6168198

Group type: EXPERIMENTAL
Intervention: Nasogastric suction
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nothing by mouth (control)
Number of subjects: 21
Study: 31755037

Group type: EXPERIMENTAL
Intervention: Experimental group (54 cases)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (18 cases)
Number of subjects: 72
Study: 30687986

Group type: EXPERIMENTAL
Intervention: StudiCare SAD (unguided internet-based self-help intervention)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: StudiCare SAD
Number of subjects: 200

Group type: COMPARATOR
Intervention: Waitlist control group (WLC) with full access to treatment as usual
Number of subjects: 200
Study: 28500516

Group type: COMPARATOR
Intervention: PLA (placebo gel)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: PLA + laser
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Laser (Nd:YAG)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: F + Sn + E + laser
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: F + E + laser
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: F
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: F + laser
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: F + Sn + MB + laser
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: F + MB + laser
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: F + Sn
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: F + Sn + laser
Number of subjects: 8
Study: 25768712

Group type: EXPERIMENTAL
Intervention: Epilepsy health education group (90 subjects) received a structured educational program consisting of 4 sessions.
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (90 subjects) received standard of care without structured educational program.
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Both groups (Epilepsy health education and Control) assessed using ESES scores.
Number of subjects: 180
Study: 24829961

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham-tape
Number of subjects: 19
Study: 21949034

Group type: EXPERIMENTAL
Intervention: Mean Platelet Volume (MPV)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Mean Platelet Mass (MPM)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Mean Platelet Component (MPC)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Platelet activity indices (MPV, MPM, MPC)
Number of subjects: 203
Study: 19625978

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Alpha-2 agonists (clonidine and guanfacine)
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (supratherapeutic doses)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 477
Study: 17519409

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine
Number of subjects: 767

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 767

Group type: EXPERIMENTAL
Intervention: Chlorproguanil-dapsone
Number of subjects: 767

Group type: COMPARATOR
Intervention: Chloroquine and sulfadoxine-pyrimethamine
Number of subjects: 767
Study: 15165648

Group type: EXPERIMENTAL
Intervention: Family‐Focused Grief Therapy (FFGT)
Number of subjects: 81
Study: 11419830

Group type: EXPERIMENTAL
Intervention: Targeted educational session (group 1)
Number of subjects: 142

Group type: COMPARATOR
Intervention: No educational session (group 2)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Telephonic instruction (group 3)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 142
Study: 9735523

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention implemented by regular staff
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control hospitals (no specific intervention mentioned)
Number of subjects: 0
Study: 7981389

Group type: EXPERIMENTAL
Intervention: Short-duration chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-duration chemotherapy
Number of subjects: 0
Study: 2662740

Group type: EXPERIMENTAL
Intervention: APSAC treatment
Number of subjects: 1004

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 1004
Study: 236337

Group type: EXPERIMENTAL
Intervention: pipradrol‐vitamin (Alertonic) elixir
Number of subjects: 99

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 99

Group type: COMPARATOR
Intervention: no treatment
Number of subjects: 99
Study: 31145308

Group type: EXPERIMENTAL
Intervention: rhACE2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ang II
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 29231341

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 29

Group type: COMPARATOR
Intervention: Diane-35 (western medication)
Number of subjects: 29
Study: 25331845

Group type: EXPERIMENTAL
Intervention: Unilateral baroreflex activation therapy (BAT)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Right-sided stimulation
Number of subjects: 295

Group type: COMPARATOR
Intervention: Bilateral baroreflex activation therapy (BAT)
Number of subjects: 295
Study: 24021393

Group type: EXPERIMENTAL
Intervention: Multi-component intervention including health ambassador, study circle for caregivers, and health course for residents, lasting 12-16 months.
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract).
Number of subjects: 130
Study: 21471085

Group type: EXPERIMENTAL
Intervention: Vardenafil (5 mg twice daily)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 17418218

Group type: EXPERIMENTAL
Intervention: Roxithromycin 300 mg daily for 28 days
Number of subjects: 507

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 507
Study: 15795006

Group type: EXPERIMENTAL
Intervention: Directive augmented information feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: No augmented information feedback
Number of subjects: 0
Study: 12559860

Group type: EXPERIMENTAL
Intervention: rhIL‐11 50 microg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10751379

Group type: EXPERIMENTAL
Intervention: 'Safe in the Sun' curriculum programme
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Teachers using materials as recommended
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: All levels of intervention
Number of subjects: 11
Study: 8785139

Group type: EXPERIMENTAL
Intervention: alfentanil‐nitrous oxide‐oxygen‐isoflurane (n = 10)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: alfentanil‐nitrous oxide‐oxygen‐sevoflurane (n = 10)
Number of subjects: 90

Group type: COMPARATOR
Intervention: alfentanil‐nitrous oxide‐oxygen (n = 10)
Number of subjects: 90
Study: 1494924

Group type: EXPERIMENTAL
Intervention: 15.2-cm catheter
Number of subjects: 89

Group type: COMPARATOR
Intervention: 4.45-cm catheter
Number of subjects: 89
Study: 6466255

Group type: EXPERIMENTAL
Intervention: Acetazolamide 500 mg daily
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31464859

Group type: EXPERIMENTAL
Intervention: Short-term follow-up (0-27 months)
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Having 2 or more lifetime sex partners
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: History of any sexually transmitted disease
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Entire follow-up (0-76 months)
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Greater number of lifetime partners
Number of subjects: 534
Study: 30259644

Group type: EXPERIMENTAL
Intervention: Mealtime faster aspart
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Post-meal faster aspart
Number of subjects: 1025

Group type: COMPARATOR
Intervention: IAsp
Number of subjects: 1025
Study: 25924097

Group type: EXPERIMENTAL
Intervention: Observation of video of themselves in pain
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Observation of video of spouse in pain
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lukewarm water immersion without empathic observation
Number of subjects: 30
Study: 25317091

Group type: EXPERIMENTAL
Intervention: Gabapentin 250 mg
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study: 22331056

Group type: EXPERIMENTAL
Intervention: Sildenafil (20 mg tid for 6 weeks)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 20819324

Group type: EXPERIMENTAL
Intervention: Acetaminophen (4000 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prednisone therapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 30
Study: 17460335

Group type: EXPERIMENTAL
Intervention: Novedex XT
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 12804077

Group type: EXPERIMENTAL
Intervention: 7.5 g of aromatics inunction
Number of subjects: 12

Group type: COMPARATOR
Intervention: Petrolatum placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: No-treatment baseline
Number of subjects: 12
Study: 11112238

Group type: EXPERIMENTAL
Intervention: Raloxifene 30 mg
Number of subjects: 1145

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 1145

Group type: EXPERIMENTAL
Intervention: Raloxifene 150 mg
Number of subjects: 1145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1145

Group type: EXPERIMENTAL
Intervention: All Raloxifene groups
Number of subjects: 1145

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1145
Study: 9364981

Group type: EXPERIMENTAL
Intervention: High levels of antiprothrombin antibodies
Number of subjects: 530

Group type: COMPARATOR
Intervention: Control group (matched controls with no thromboembolic events)
Number of subjects: 530
Study: 7968334

Group type: EXPERIMENTAL
Intervention: Closed Airway Suctioning (CAS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard Suctioning (SS)
Number of subjects: 16
Study: 2872059

Group type: EXPERIMENTAL
Intervention: Bevantolol 400 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 29777404

Group type: EXPERIMENTAL
Intervention: Locoregional treatment (LRT)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Systemic therapy (ST)
Number of subjects: 274
Study: 26945315

Group type: EXPERIMENTAL
Intervention: Tissue preservation
Number of subjects: 25
Study: 24833235

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 14264

Group type: EXPERIMENTAL
Intervention: Other AADs
Number of subjects: 14264

Group type: COMPARATOR
Intervention: Warfarin with Amiodarone
Number of subjects: 14264

Group type: COMPARATOR
Intervention: Rivaroxaban vs Warfarin (no AAD)
Number of subjects: 14264
Study: 22569564

Group type: EXPERIMENTAL
Intervention: ITN protection from birth
Number of subjects: 120

Group type: COMPARATOR
Intervention: ITN protection from month six onwards
Number of subjects: 120
Study: 20194359

Group type: EXPERIMENTAL
Intervention: Smokers with a quit date
Number of subjects: 283

Group type: COMPARATOR
Intervention: Smokers without a quit date
Number of subjects: 283
Study: 17891382

Group type: EXPERIMENTAL
Intervention: Bromocriptine (dopamine D2 agonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Haloperidol (dopamine D2 antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15953423

Group type: EXPERIMENTAL
Intervention: Placebo treatment
Number of subjects: 0
Study: 12701826

Group type: COMPARATOR
Intervention: Cr‐mH (0.125 g/kg/day)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Cr‐mH (0.075 g/kg/day)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Cr‐mH (mean = 0.18 g/kg/day)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Weight training in young men
Number of subjects: 57

Group type: COMPARATOR
Intervention: Weight training in elderly subjects
Number of subjects: 57
Study: 10483801

Group type: EXPERIMENTAL
Intervention: 1.21 liters of water (W)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Saline (S) containing 100 mmol of NaCl x l(‐1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: No fluid (NF)
Number of subjects: 6
Study: 8709370

Group type: EXPERIMENTAL
Intervention: Intravesical capsaicin (10 microM, twice weekly for 1 month)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 1897307

Group type: EXPERIMENTAL
Intervention: 0.025 mg Pasteur BCG by intradermal injection
Number of subjects: 291

Group type: COMPARATOR
Intervention: 0.05 mg Pasteur BCG by intradermal injection
Number of subjects: 291
Study: 7160389

Group type: EXPERIMENTAL
Intervention: Mobile Coronary Care Unit (MCCU)
Number of subjects: 821

Group type: COMPARATOR
Intervention: Standard Ambulance (STA)
Number of subjects: 821
Study: 31246370

Group type: EXPERIMENTAL
Intervention: ACT group (n = 22)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: DBT group (n = 20)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Combined ACT + DBT + FAP therapy group (n = 23)
Number of subjects: 65

Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 65
Study: 31465494

Group type: EXPERIMENTAL
Intervention: Non-citizens (n = 369)
Number of subjects: 57556

Group type: EXPERIMENTAL
Intervention: Non-citizens (n = 2,463)
Number of subjects: 57556

Group type: EXPERIMENTAL
Intervention: Non-citizens with knowledge of HIV-positive status (n = 72)
Number of subjects: 57556
Study: 27798754

Group type: EXPERIMENTAL
Intervention: To-be-ignored auditory distractor words from different categories
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quiet control condition
Number of subjects: 0
Study: 25811947

Group type: EXPERIMENTAL
Intervention: Parallel-depth heavy squat-lift training (HS-P)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Parallel-depth jump squat training (JS-P)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Volitional-depth jump squat training (JS-V)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No training (C)
Number of subjects: 36
Study: 24478107

Group type: EXPERIMENTAL
Intervention: RS4-enriched flour (30% v/v)
Number of subjects: 86